42 CFR § 93.101 - Purpose.

---
identifier: "/us/cfr/t42/s93.101"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "42 CFR § 93.101 - Purpose."
title_number: 42
title_name: "Public Health"
section_number: "93.101"
section_name: "Purpose."
chapter_name: "PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "H"
subchapter_name: "HEALTH ASSESSMENTS AND HEALTH EFFECTS STUDIES OF HAZARDOUS SUBSTANCES RELEASES AND FACILITIES"
part_number: "93"
part_name: "PUBLIC HEALTH SERVICE POLICIES ON RESEARCH MISCONDUCT"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "42 U.S.C. 216 and 289b"
regulatory_source: "89 FR 76295, Sept. 17, 2024, unless otherwise noted."
cfr_part: "93"
---


# 93.101 Purpose.

The purpose of this part is to—

(a) Establish the responsibilities of HHS, the Office of Research Integrity (ORI), and institutions in addressing allegations of research misconduct;

(b) Define what constitutes research misconduct in PHS-supported research;

(c) Establish the requirements for a finding of research misconduct;

(d) Define the general types of administrative actions HHS may take in response to research misconduct;

(e) Require institutions to:

(1) Develop and implement policies and procedures for reporting and addressing allegations of research misconduct covered by this part;

(2) Provide HHS with the assurances necessary to permit institutions to participate in PHS-supported research;

(f) Protect the health and safety of the public, promote the integrity of PHS-supported research and the research process, and conserve public funds.